secwatch.observer — SEC 8-K summary
======================================

Issuer:     STERIS plc (STE)
CIK:        0001757898
Form:       8-K
Filed at:   2026-05-11T20:34:04+00:00
Accession:  0001628280-26-033580
Event type: earnings
Sentiment:  positive
Materiality: 0.90
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

STERIS FY26 revenue $5.9B (+9%), adj EPS $10.17; FY27 guidance adj EPS $11.10-$11.30
--------------------------------------------------------------------------------

- Full year revenue from continuing ops $5.9B (+9%), constant currency organic +7%; adjusted EPS $10.17 vs $9.22.
- Q4 revenue $1.6B (+7%), adjusted EPS $2.83 vs $2.74; Healthcare rev $1.14B (+7%), AST $289.2M (+6%), Life Sci $162.9M (+9%).
- FY26 operating cash flow $1.34B, free cash flow $982.9M (up from $787.2M).
- FY27 guidance: revenue +7-8%, organic +6-7%, adj EPS $11.10-$11.30 (9-11% growth), capex ~$375M, FCF ~$850M.
- Board authorized new $1B share repurchase program; $60M strategic investment for new sterility plant in Mentor, Ohio (operational late CY2027).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757898/000162828026033580/0001628280-26-033580-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757898/000162828026033580/ste-20260511.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-033580

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer